< Back to
< Back to all News
Global Alzheimer’s Platform Taps Alumnus Jason Bork to Lead Project Management
October 2, 2014
By 2050, World Health Organization Director Margaret Chan estimates that 135 million people will be living with Alzheimer’s and dementia, if aggressive action isn’t taken now. That’s why the newly formed Global Alzheimer’s Platform (GAP) has tapped alumnus Jason Bork as a project management lead.
Bork, a 1995 chemical engineering graduate, hopes to help program reduce the time and cost of Alzheimer’s clinical trials, develop an infrastructure that promotes innovation, and assure international collaboration. He plans to develop a patient registry infrastructure, and a pre-qualified network of trial sites that enable innovative trial execution and leverage international collaboration.
“GAP has very aggressive goals focused mainly on accelerating clinical studies of promising drug candidates,” says Bork, who will work closely with pharmaceutical partners and GAP leadership. “We are working quickly to develop a program with a robust, global patient registry. Our plan is to also pre-certify clinical trial sites and implement agreed-upon standards so the time needed to conduct clinical trials is greatly compressed.”
GAP was launched in February by the Global CEO Initiative on Alzheimer’s disease and the New York Academy of Sciences.
Bork is on loan from an executive position with YourEncore, a company that helps life sciences, consumer products, and food companies solve complex innovation, compliance, and productivity challenges by deploying industry-accomplished experts. His career has also featured having global responsibilities for project management at Covance Central Laboratories, and 13 years at Eli Lilly and Company in project management leadership roles, product research and development, and manufacturing.